Lv4
490 积分 2024-04-28 加入
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2天前
已完结
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial
2天前
已完结
Type 2 diabetes mellitus
3天前
已完结
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
18天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
1个月前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
1个月前
已完结
皖公网安备34019202002308
